<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8761381" created="22/08/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>8761381</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Transcriptional analysis of <term id="A101" sem="DNA_domain_or_region"><term id="T1" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> gene</term> <term id="T2" lex="gene_expression" sem="Other">expression</term> in <term id="T3" lex="EBV-positive_gastric_carcinoma" sem="Tissue_natural"><term id="A102" sem="Virus">EBV</term>-positive gastric carcinoma</term>: unique <term id="T4" lex="viral_latency" sem="Other">viral latency</term> in the <term id="T5" lex="tumour_cell" sem="Cell_natural">tumour cells</term>.</sentence>
<event KT="Investigation" id="E1">
<type class="Gene_expression"/>
<theme idref="A101"/>
<clue>Transcriptional <clueKT>analysis</clueKT> of Epstein-Barr virus gene <clueType>expression</clueType> <clueLoc>in EBV-positive gastric carcinoma</clueLoc>: unique viral latency in the tumour cells.</clue>
<comment>NER T2 MOD</comment></event>
<event KT="Investigation" id="E2">
<type class="Viral_life_cycle"/>
<theme idref="T1"/>
<clue>Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique <corefTheme>viral</corefTheme> <clueType>latency</clueType> <clueLoc>in the tumour cells</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Although case-oriented evidence for an association of <term id="T6" lex="Epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> (<term id="T7" lex="EBV" sem="Virus">EBV</term>) with <term id="T8" lex="gastric_carcinoma" sem="Other">gastric carcinoma</term> has been accumulating recently, the interaction(s) between <term id="T9" lex="EBV" sem="Virus">EBV</term> and <term id="T10" lex="gastric_epithelial_cell" sem="Cell_natural">gastric epithelial cells</term> is/are largely unknown.</sentence>
<event KT="Analysis" id="E3">
<type class="Correlation"/>
<theme idref="T6"/>
<theme idref="T7"/>
<clue>Although case-oriented <clueKT>evidence</clueKT> for an <clueType><clueKT>association</clueKT></clueType> <linkTheme>of</linkTheme> Epstein-Barr virus (EBV) <linkTheme>with</linkTheme> gastric carcinoma has been accumulating recently, the interaction(s) between EBV and gastric epithelial cells is/are largely unknown.</clue>
</event>
<event KT="Other" id="E4" uncertainty="doubtful">
<type class="Correlation"/>
<theme idref="T9"/>
<theme idref="T10"/>
<clue>Although case-oriented evidence for an association of Epstein-Barr virus (EBV) with gastric carcinoma has been accumulating recently, the <clueType>interaction</clueType>(s) <linkTheme>between</linkTheme> EBV <linkTheme>and</linkTheme> gastric epithelial cells is/are largely unknown.</clue>
</event>
<sentence id="S3">In this study, we examined seven <term id="T11" lex="EBV-positive_gastric_carcinoma_tissue" sem="Tissue_natural"><term id="T12" lex="EBV" sem="Virus">EBV</term>-positive <term id="T13" lex="gastric_carcinoma" sem="Other">gastric carcinoma</term> tissues</term> for <term id="T14" lex="viral_gene_expression" sem="Other">viral gene expression</term> at the <term id="T15" lex="mRNA_level" sem="Other">mRNA level</term>, from which studies on the <term id="T16" lex="EBV" sem="Virus">EBV</term> oncogenicity in <term id="T17" lex="human_epithelial_cell" sem="Cell_natural">human epithelial cells</term> will benefit.</sentence>
<event KT="Investigation" id="E5">
<type class="Gene_expression"/>
<theme idref="T12"/>
<clue>In this study, we <clueKT>examined</clueKT> <clueLoc>seven EBV-positive gastric carcinoma tissues</clueLoc> for <corefTheme>viral gene</corefTheme> <clueType>expression</clueType> at the mRNA level, from which studies on the EBV oncogenicity in human epithelial cells will benefit.</clue>
</event>
<event KT="Investigation" id="E105">
<type/>
<cause idref="T16"/>
<clue>In this study, we examined seven EBV-positive gastric carcinoma tissues for viral gene expression at the mRNA level, from which <clueKT>studies</clueKT> on the EBV <clueType>oncogenicity</clueType> <clueLoc>in human epithelial cells</clueLoc> will benefit.</clue>
<comment>SOO</comment></event>
<sentence id="S4"><term id="T18" lex="reverse_transcription-PCR_analysis" sem="Other">Reverse transcription-PCR analysis</term> showed that all seven <term id="T19" lex="EBV-positive_tumour_tissue" sem="Tissue_natural"><term id="T20" lex="EBV" sem="Virus">EBV</term>-positive tumour tissues</term> constitutively expressed <term id="T21" lex="EBV_nuclear_antigen_(EBNA)_1_mRNA" sem="RNA_molecule"><term id="T22" lex="EBV_nuclear_antigen" sem="Protein_family_or_group"><term id="T23" lex="EBV" sem="Virus">EBV</term> nuclear antigen</term> (<term id="T24" lex="EBNA" sem="Protein_family_or_group">EBNA</term>) 1 mRNA</term>, but not <term id="T25" lex="EBNA2_mRNA" sem="RNA_molecule">EBNA2 mRNA</term>.</sentence>
<event KT="Analysis" id="E6">
<type class="Gene_expression"/>
<theme idref="T21"/>
<clue><clueExperiment>Reverse transcription-PCR analysis</clueExperiment> <clueKT>showed</clueKT> that <clueLoc>all seven EBV-positive tumour tissues</clueLoc> constitutively <clueType>expressed</clueType> EBV nuclear antigen (EBNA) 1 mRNA, but not EBNA2 mRNA.</clue>
</event>
<event KT="Analysis" Polarity="Negative" assertion="non-exist" id="E7">
<type class="Gene_expression"/>
<theme idref="T25"/>
<clue><clueExperiment>Reverse transcription-PCR analysis</clueExperiment> <clueKT>showed</clueKT> that <clueLoc>all seven EBV-positive tumour tissues</clueLoc> constitutively <clueType>expressed</clueType> EBV nuclear antigen (EBNA) 1 mRNA, but <cluePolarity>not</cluePolarity> EBNA2 mRNA.</clue>
</event>
<sentence id="S5">The <term id="T26" lex="EBNA_transcription" sem="Other"><term id="T27" lex="EBNA" sem="Protein_family_or_group">EBNA</term> transcription</term> was initiated from one of three <term id="T28" lex="EBNA_promoter" sem="DNA_domain_or_region"><term id="T29" lex="EBNA" sem="Protein_family_or_group">EBNA</term> promoters</term>, <term id="T30" lex="Qp" sem="DNA_domain_or_region">Qp</term>: by contrast, both <term id="T31" lex="Cp" sem="DNA_domain_or_region">Cp</term> and <term id="T32" lex="Wp" sem="DNA_domain_or_region">Wp</term> were silent, thus resulting in the lack of <term id="T33" lex="EBNA2_mRNA" sem="RNA_molecule">EBNA2 mRNA</term>.</sentence>
<event id="E8">
<type class="Transcription"/>
<theme idref="T27"/>
<clue>The EBNA <clueType>transcription</clueType> was initiated from one of three EBNA promoters, Qp: by contrast, both Cp and Wp were silent, thus resulting in the lack of EBNA2 mRNA.</clue>
</event>
<event id="E9">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T30"/>
<clue>The EBNA transcription was <clueType>initiated</clueType> <linkCause>from</linkCause> one of three EBNA promoters, Qp: by contrast, both Cp and Wp were silent, thus resulting in the lack of EBNA2 mRNA.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E10">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T31"/>
<clue>The EBNA transcription was initiated from one of three EBNA promoters, Qp: by contrast, both Cp and Wp were <clueType><cluePolarity>silent</cluePolarity></clueType>, thus resulting in the lack of EBNA2 mRNA.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E11">
<type class="Positive_regulation"/>
<theme idref="E8"/>
<cause idref="T32"/>
<clue>The EBNA transcription was initiated from one of three EBNA promoters, Qp: by contrast, both Cp and Wp were <clueType><cluePolarity>silent</cluePolarity></clueType>, thus resulting in the lack of EBNA2 mRNA.</clue>
</event>
<event KT="Other" Polarity="Negative" assertion="non-exist" id="E12">
<type class="Transcription"/>
<theme idref="T33"/>
<clue>The EBNA transcription was initiated from one of three EBNA promoters, Qp: by contrast, both Cp and Wp were silent, thus resulting in the <clueType><cluePolarity>lack</cluePolarity></clueType> <linkTheme>of</linkTheme> EBNA2 mRNA.</clue>
</event>
<event KT="Analysis" id="E13">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E10"/>
<cause idref="E11"/>
<clue>The EBNA transcription was initiated from one of three EBNA promoters, Qp: by contrast, both Cp and Wp were silent, <linkCause><clueKT>thus</clueKT></linkCause> <clueType>resulting</clueType> <linkTheme>in</linkTheme> the lack of EBNA2 mRNA.</clue>
</event>
<sentence id="S6"><term id="T34" lex="latent_membrane_protein_(LMP)_2A_mRNA" sem="RNA_molecule"><term id="T35" lex="latent_membrane_protein_(LMP)_2A" sem="Protein_molecule">Latent membrane protein (LMP) 2A</term> mRNA</term> was detected in three of seven cases; however, neither <cons id="C1" lex="(OR LMP1_mRNA LMP2B_mRNA)" sem="(OR RNA_molecule RNA_molecule)"><frag id="F1">LMP1</frag> nor <frag id="F2">LMP2B</frag> <frag id="F3">mRNA</frag></cons> was detected in any of the <term id="T37" lex="tumour" sem="Tissue_natural">tumours</term> tested.</sentence>
<event id="E14">
<type class="Transcription"/>
<theme idref="T34"/>
<clue>Latent membrane protein (LMP) 2A mRNA was <clueType><clueKT>detected</clueKT></clueType> <clueLoc>in three of seven cases;</clueLoc> however, neither LMP1 nor LMP2B mRNA was detected in any of the tumours tested.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E15">
<type class="Transcription"/>
<theme idref="F1" idref1="F3"/>
<clue>Latent membrane protein (LMP) 2A mRNA was detected in three of seven cases; however, <cluePolarity>neither</cluePolarity> LMP1 nor LMP2B mRNA was <clueType><clueKT>detected</clueKT></clueType> <clueLoc>in any of the tumours tested</clueLoc>.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E16">
<type class="Transcription"/>
<theme idref="F2" idref1="F3"/>
<clue>Latent membrane protein (LMP) 2A mRNA was detected in three of seven cases; however, neither LMP1 <cluePolarity>nor</cluePolarity> LMP2B mRNA was <clueType><clueKT>detected</clueKT></clueType> <clueLoc>in any of the tumours tested</clueLoc>.</clue>
</event>
<sentence id="S7">Transcripts from the <term id="T38" lex="BamHI-A_region" sem="DNA_domain_or_region">BamHI-A region</term> of the <term id="T39" lex="viral_genome" sem="DNA_family_or_group">viral genome</term> were detectable in all cases.</sentence>
<event id="E17">
<type class="Transcription"/>
<theme idref="T38"/>
<clue><clueType>Transcripts</clueType> <linkTheme>from</linkTheme> the BamHI-A region of the viral genome were <clueKT>detectable</clueKT> <clueLoc>in all cases</clueLoc>.</clue>
</event>
<sentence id="S8"><term id="T40" lex="BZLF1_mRNA" sem="RNA_molecule"><term id="A103" sem="Protein_molecule">BZLF1</term> mRNA</term> and the product, an <term id="T41" lex="immediate-early_gene" sem="DNA_family_or_group">immediate-early gene</term> for <term id="T42" lex="EBV" sem="Virus">EBV</term> replication, was not expressed in any of them, thereby suggesting that the <term id="T43" lex="tumour_cell" sem="Cell_natural">tumour cells</term> carried <term id="T44" lex="EBV_genome" sem="DNA_family_or_group"><term id="T45" lex="EBV" sem="Virus">EBV</term> genomes</term> in a tightly latent form.</sentence>
<event KT="Other" id="E18">
<type class="Viral_life_cycle"/>
<theme idref="T42"/>
<clue>BZLF1 mRNA and the product, an immediate-early gene for EBV <clueType>replication</clueType>, was not expressed in any of them, thereby suggesting that the tumour cells carried EBV genomes in a tightly latent form.</clue>
</event>
<event KT="Fact" id="E19">
<type class="Positive_regulation"/>
<theme idref="E18"/>
<cause idref="A103"/>
<clue>BZLF1 mRNA and <corefCause>the product</corefCause>, an immediate-early gene <clueType>for</clueType> EBV replication, was not expressed in any of them, thereby suggesting that the tumour cells carried EBV genomes in a tightly latent form.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E20">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>BZLF1 mRNA and the product, an immediate-early gene for EBV replication, was <cluePolarity>not</cluePolarity> <clueType>expressed</clueType> <clueLoc>in any of them</clueLoc>, thereby suggesting that the tumour cells carried EBV genomes in a tightly latent form.</clue>
</event>
<event Polarity="Negative" assertion="non-exist" id="E21">
<type class="Gene_expression"/>
<theme idref="T40"/>
<clue>BZLF1 mRNA and <corefCause>the product</corefCause>, an immediate-early gene for EBV replication, was <cluePolarity>not</cluePolarity> <clueType>expressed</clueType> <clueLoc>in any of them</clueLoc>, thereby suggesting that the tumour cells carried EBV genomes in a tightly latent form.</clue>
</event>
<sentence id="S9">These findings further extended our previous data regarding <term id="T46" lex="EBV_latency" sem="Other"><term id="T47" lex="EBV" sem="Virus">EBV</term> latency</term> in <term id="T48" lex="gastric_carcinoma_cell" sem="Cell_natural"><term id="T49" lex="gastric_carcinoma" sem="Other">gastric carcinoma</term> cells</term> at the protein level, and have affirmed that the programme of <term id="T50" lex="viral_gene_expression" sem="Other">viral gene expression</term> in the tumour more closely resembles <term id="T51" lex="&apos;latency_I&apos;" sem="Other">&apos;latency I&apos;</term> represented by <term id="T52" lex="Burkitt&apos;s_lymphoma" sem="Other">Burkitt&apos;s lymphoma</term> than <term id="T53" lex="&apos;latency_II&apos;" sem="Other">&apos;latency II&apos;</term> represented by the majority of <term id="T54" lex="nasopharyngeal_carcinoma" sem="Other">nasopharyngeal carcinomas</term>.</sentence>
<event KT="Other" id="E22">
<type class="Gene_expression"/>
<theme idref="T47"/>
<clue>These findings further extended our previous data regarding EBV latency in gastric carcinoma cells at the protein level, and have affirmed that the programme of <corefTheme>viral gene</corefTheme> <clueType>expression</clueType> <clueLoc>in the tumour</clueLoc> more closely resembles &apos;latency I&apos; represented by Burkitt&apos;s lymphoma than &apos;latency II&apos; represented by the majority of nasopharyngeal carcinomas.</clue>
</event>
<event KT="Analysis" id="E23">
<type class="Regulation"/>
<theme idref="E22"/>
<clue>These findings further extended our previous data regarding EBV latency in gastric carcinoma cells at the protein level, and have <clueKT>affirmed</clueKT> that the <clueType>programme</clueType> <linkTheme>of</linkTheme> viral gene expression in the tumour more closely resembles &apos;latency I&apos; represented by Burkitt&apos;s lymphoma than &apos;latency II&apos; represented by the majority of nasopharyngeal carcinomas.</clue>
</event>
<event Source="Other" id="E123">
<type class="Regulation"/>
<theme idref="T47"/>
<clue>These findings further extended <clueSource>our previous data</clueSource> regarding EBV <clueType>latency</clueType> <clueLoc>in gastric carcinoma cells</clueLoc> at the protein level, and have affirmed that the programme of viral gene expression in the tumour more closely resembles &apos;latency I&apos; represented by Burkitt&apos;s lymphoma than &apos;latency II&apos; represented by the majority of nasopharyngeal carcinomas.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
